Comprehensive molecular analysis of several prognostic signatures using molecular indices related to hallmarks of breast cancer: proliferation index appears to be the most significant component of all signatures.

被引：0

作者：

Sotiriou, C.

Haibe-Kains, B.

Desmedt, C.

Wirapati, P.

Harris, A.

Larsimont, D.

Bontempi, G.

Buyse, M.

Delorenzi, M.

Piccart, M.

机构：

[1] Inst Jules Bordet, B-1000 Brussels, Belgium

[2] Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland

[3] Univ Oxford, Oxford, England

[4] Univ Libre Bruxelles, Brussels, Belgium

[5] Int Inst Drug Dev, Brussels, Belgium

来源：

BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S86 / S86

页数：1

共 8 条

[1] Molecular profiling of breast cancer cell lines using signatures reported in prognostic and predictive patient studies
Sninsky, John
Kwok, Shirley
Wang, Alice
Kim, Wontae
Lagier, Robert
Christopherson, Cindy
Rowland, Charley
Waldman, Fred
Tutt, Andrew
Broder, Sam
Esserman, Laura
Benz, Chris
[J]. MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
[2] Comparative analysis of molecular signatures reveals a hybrid approach in breast cancer: Combining the Nottingham Prognostic Index with gene expressions into a hybrid signature
Tschodu, Dimitrij
Ulm, Bernhard
Bendrat, Klaus
Lippoldt, Jurgen
Gottheil, Pablo
Kaes, Josef A.
Niendorf, Axel
[J]. PLOS ONE, 2022, 17 (02):
[3] A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer
Fabien Reyal
Martin H van Vliet
Nicola J Armstrong
Hugo M Horlings
Karin E de Visser
Marlen Kok
Andrew E Teschendorff
Stella Mook
Laura van 't Veer
Carlos Caldas
Remy J Salmon
Marc J van de Vijver
Lodewyk FA Wessels
[J]. Breast Cancer Research, 10
[4] A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer
Reyal, Fabien
van Vliet, Martin H.
Armstrong, Nicola J.
Horlings, Hugo M.
de Visser, Karin E.
Kok, Marlen
Teschendorff, Andrew E.
Mook, Stella
van 't Veer, Laura
Caldas, Carlos
Salmon, Remy J.
van de Vijver, Marc J.
Wessels, Lodewyk F. A.
[J]. BREAST CANCER RESEARCH, 2008, 10 (06)
[5] EndoPredict prognostic signature in pN1mi, estrogen receptor-positive breast cancer: analysis of the French national registry for molecular signatures
LaCroix-Triki, M.
Arnould, L.
MacGrogan, G.
Penault-Llorca, F.
Haudebourg, J.
Tas, P.
Garnier, A.
Vincent-Salomon, A.
Miquel, C.
Lehmann-Che, J.
Callens, C.
Quillien, V.
Cayre, A.
Lamy, P-J
Rouleau, E.
De Cremoux, P.
[J]. CANCER RESEARCH, 2019, 79 (04)
[6] Transcriptome-Based Network Analysis Unveils Eight Immune-Related Genes as Molecular Signatures in the Immunomodulatory Subtype of Triple-Negative Breast Cancer
Zhang, Jinguo
Wang, Li
Xu, Xiaolin
Li, Xin
Guan, Wencai
Meng, Ting
Xu, Guoxiong
[J]. FRONTIERS IN ONCOLOGY, 2020, 10
[7] Comprehensive analysis integrating both clinicopathological and gene expression data in more than 1,500 samples: Proliferation captured by gene expression grade index appears to be the strongest prognostic factor in breast cancer (BC).
Sotiriou, C.
Wirapati, P.
Loi, S.
Haibe-Kains, B.
Desmedt, C.
Tutt, A.
Ellis, P.
Buyse, M.
Delorenzi, M.
Piccart, M.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 4S - 4S
[8] Which factor of metastatic lymph nodes-The number, tumor volume or anatomical location-Is independently prognostic in breast cancer? - A prospective cohort study using molecular whole-node analysis of all removed axillary nodes
Osako, T.
Iwase, T.
Ushijima, M.
Ogiya, A.
Ueno, T.
Ohno, S.
Akiyama, F.
[J]. CANCER RESEARCH, 2019, 79 (04)

← 1 →